Mengis Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93M | Buy |
8,894
+1,560
| +21% | +$1.22M | 1.47% | 17 |
|
|
2025
Q1 | $6.06M | Sell |
7,334
-199
| -3% | -$164K | 1.26% | 19 |
|
|
2024
Q4 | $5.82M | Sell |
7,533
-26
| -0.3% | -$20.1K | 1.19% | 19 |
|
|
2024
Q3 | $6.7M | Buy |
7,559
+160
| +2% | +$142K | 1.32% | 18 |
|
|
2024
Q2 | $6.7M | Sell |
7,399
-75
| -1% | -$67.9K | 1.36% | 18 |
|
|
2024
Q1 | $5.81M | Buy |
7,474
+145
| +2% | +$113K | 0.9% | 25 |
|
|
2023
Q4 | $4.27M | Sell |
7,329
-20
| -0.3% | -$11.7K | 0.8% | 31 |
|
|
2023
Q3 | $3.95M | Buy |
7,349
+124
| +2% | +$66.6K | 0.82% | 29 |
|
|
2023
Q2 | $3.39M | Buy |
7,225
+5
| +0.1% | +$2.35K | 0.68% | 41 |
|
|
2023
Q1 | $2.48M | Buy |
7,220
+57
| +0.8% | +$19.6K | 0.52% | 56 |
|
|
2022
Q4 | $2.62M | Buy |
7,163
+5
| +0.1% | +$1.83K | 0.57% | 53 |
|
|
2022
Q3 | $2.31M | Buy |
7,158
+6
| +0.1% | +$1.94K | 0.55% | 53 |
|
|
2022
Q2 | $2.32M | Buy |
7,152
+6
| +0.1% | +$1.95K | 0.51% | 58 |
|
|
2022
Q1 | $2.05M | Buy |
7,146
+2,207
| +45% | +$632K | 0.39% | 64 |
|
|
2021
Q4 | $1.36M | Buy |
4,939
+6
| +0.1% | +$1.66K | 0.26% | 83 |
|
|
2021
Q3 | $1.14M | Buy |
4,933
+7
| +0.1% | +$1.62K | 0.24% | 86 |
|
|
2021
Q2 | $1.13M | Buy |
4,926
+1,107
| +29% | +$254K | 0.23% | 88 |
|
|
2021
Q1 | $713K | Buy |
3,819
+1,008
| +36% | +$188K | 0.16% | 108 |
|
|
2020
Q4 | $474K | Buy |
2,811
+8
| +0.3% | +$1.35K | 0.12% | 120 |
|
|
2020
Q3 | $414K | Buy |
2,803
+17
| +0.6% | +$2.51K | 0.11% | 116 |
|
|
2020
Q2 | $457K | Buy |
2,786
+9
| +0.3% | +$1.48K | 0.14% | 113 |
|
|
2020
Q1 | $385K | Buy |
+2,777
| New | +$385K | 0.13% | 113 |
|